31 October 2024

REIG JOFRE submits press release on 2024 third quarter results

18 September 2024

REIG JOFRE participates in a Consortium to validate and scale-up the human skin production generated by a 3D bioprinter

10 September 2024

REIG JOFRE opens a subsidiary in Czech Republic

30 July 2024

REIG JOFRE submits press release on the results of the first half of 2024

18 June 2024

REIG JOFRE joins the IBEX SMALL CAP INDEX

29 May 2024

REIG JOFRE participates as an Associated Partner in Med4Cure, the first major European project for the industrialization of new therapies

10 May 2024

REIG JOFRE submits the conditions and report of the Scrip Dividend

9 May 2024

REIG JOFRE submits press release on the results of the first quarter of 2024

8 April 2024

REIG JOFRE commits to vertical integration in the production of biotechnological medicines with an investment of eur 5.8m in Leanbio

8 March 2024

REIG JOFRE convenes its 2024 General Shareholders´ Meeting

29 February 2024

REIG JOFRE submits press release on the results of the fourth quarter of 2023

16 February 2024

Member of the European Parliament, Laura Ballarín, visits REIG JOFRE plant in Barcelona

20 December 2023

Appointment of the new Chief Financial Officer (CFO)

2 November 2023

REIG JOFRE reaches the milestone of 15 million vials of its intravenous anesthetic sold in Japan

30 October 2023

REIG JOFRE submits press release on the results of the third quarter of 2023

26 September 2023

REIG JOFRE appointed Alex Sanfeliu as the new Global Head of Pharmaceutical Technologies business unit

27 July 2023

REIG JOFRE submits press release on the results of the second quarter of 2023

30 June 2023

Reig Jofre and Zendal appointed by the EU to ensure vaccine production capacity in Europe in case of future health emergencies

25 May 2023

REIG JOFRE joins FARMAMUNDI’s Humanitarian Action and Emergency Fund

28 February 2023

Reig Jofre convenes its 2023 General Shareholders´ Meeting